NPPA and cardiac hypertrophy: In addition, supraphysiologic doses of both VDR 4-1 and 1,25-D3 significantly decreased the expression level of biological markers for cardiac hypertrophy, such as Anf, Bnp and β-Mhc mRNA, compared to their vehicle treated littermate (Fig. 7E–H).